These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
496 related articles for article (PubMed ID: 15766414)
1. [Identification of a novel HLA-A2-restrictive CTL epitope of an ovary cancer-associated antigen OVA66]. Jin S; Wang Y; Wang SJ; Zhang HZ; Li MX; Chen Y; Ge HL Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2005 Mar; 21(2):233-6, 242. PubMed ID: 15766414 [TBL] [Abstract][Full Text] [Related]
2. Identification of an HLA-A*0201-restrictive CTL epitope from MUC4 for applicable vaccine therapy. Wu J; Wei J; Meng K; Chen J; Gao W; Zhang J; Xu Z; Miao Y Immunopharmacol Immunotoxicol; 2009; 31(3):468-76. PubMed ID: 19555216 [TBL] [Abstract][Full Text] [Related]
3. DCs pulsed with novel HLA-A2-restricted CTL epitopes against hepatitis C virus induced a broadly reactive anti-HCV-specific T lymphocyte response. Guo Z; Zhang H; Rao H; Jiang D; Cong X; Feng B; Wang J; Wei L; Chen H PLoS One; 2012; 7(6):e38390. PubMed ID: 22701633 [TBL] [Abstract][Full Text] [Related]
4. [Identification of T cell epitopes from ovarian cancer associated anti-idiotype antibody]. Li W; Cui H; Chang XH; Cheng HY; Cheng YX; Feng J; Fu TY Zhonghua Fu Chan Ke Za Zhi; 2008 Oct; 43(10):764-9. PubMed ID: 19087545 [TBL] [Abstract][Full Text] [Related]
5. Identification of known and novel immunogenic T-cell epitopes from tumor antigens recognized by peripheral blood T cells from patients responding to IL-2-based treatment. Scheibenbogen C; Sun Y; Keilholz U; Song M; Stevanovic S; Asemissen AM; Nagorsen D; Thiel E; Rammensee HG; Schadendorf D Int J Cancer; 2002 Mar; 98(3):409-14. PubMed ID: 11920592 [TBL] [Abstract][Full Text] [Related]
6. Identification of a novel HLA-A2-restricted cytotoxic T lymphocyte epitope from cancer-testis antigen PLAC1 in breast cancer. Liu W; Zhai M; Wu Z; Qi Y; Wu Y; Dai C; Sun M; Li L; Gao Y Amino Acids; 2012 Jun; 42(6):2257-65. PubMed ID: 21710262 [TBL] [Abstract][Full Text] [Related]
7. Peptide FLNPDVLDI of heparanase is a novel HLA-A2-restricted CTL epitope and elicits potent immunological antitumor effects in vitro with an 8-branched design. Zhang J; Yang J; Fan D; Tao H; Wang H; Yu T Oncol Rep; 2013 May; 29(5):1955-61. PubMed ID: 23503586 [TBL] [Abstract][Full Text] [Related]
8. Novel approach to the characterization of melanoma associated-peptide-specific CTL lines from Japanese metastatic melanoma patients. Akiyama Y; Maruyama K; Tai S; Takikawa M; Ohshita C; Yamamoto A; Yamazaki N; Kiyohara Y; Yamaguchi K Int J Oncol; 2008 Sep; 33(3):433-41. PubMed ID: 18695871 [TBL] [Abstract][Full Text] [Related]
9. Definition of an immunogenic region within the ovarian tumor antigen stratum corneum chymotryptic enzyme. Bondurant KL; Crew MD; Santin AD; O'Brien TJ; Cannon MJ Clin Cancer Res; 2005 May; 11(9):3446-54. PubMed ID: 15867247 [TBL] [Abstract][Full Text] [Related]
10. Identification of novel Lck-derived T helper epitope long peptides applicable for HLA-A2(+) cancer patients as cancer vaccine. Matsueda S; Shichijo S; Nagata S; Seki C; Yamada A; Noguchi M; Itoh K Cancer Sci; 2015 Nov; 106(11):1493-8. PubMed ID: 26331453 [TBL] [Abstract][Full Text] [Related]
11. In vitro generated cytolytic T lymphocytes reactive against head and neck cancer recognize multiple epitopes presented by HLA-A2, including peptides derived from the p53 and MDM-2 proteins. Asai T; Storkus WJ; Mueller-Berghaus J; Knapp W; DeLeo AB; Chikamatsu K; Whiteside TL Cancer Immun; 2002 Apr; 2():3. PubMed ID: 12747748 [TBL] [Abstract][Full Text] [Related]
12. Natural CD8+ T-cell responses against MHC class I epitopes of the HER-2/ neu oncoprotein in patients with epithelial tumors. Sotiropoulou PA; Perez SA; Voelter V; Echner H; Missitzis I; Tsavaris NB; Papamichail M; Baxevanis CN Cancer Immunol Immunother; 2003 Dec; 52(12):771-9. PubMed ID: 13680193 [TBL] [Abstract][Full Text] [Related]
13. Induction of human tumor-associated differentially expressed gene-12 (TADG-12/TMPRSS3)-specific cytotoxic T lymphocytes in human lymphocyte antigen-A2.1-positive healthy donors and patients with advanced ovarian cancer. Bellone S; Anfossi S; O'Brien TJ; Cannon MJ; Silasi DA; Azodi M; Schwartz PE; Rutherford TJ; Pecorelli S; Santin AD Cancer; 2009 Feb; 115(4):800-11. PubMed ID: 19117353 [TBL] [Abstract][Full Text] [Related]
14. A novel HLA-A2-restricted CTL epitope of tumor-associated antigen L6 can inhibit tumor growth in vivo. Tu SH; Huang HI; Lin SI; Liu HY; Sher YP; Chiang SK; Chong P; Roffler S; Tseng GC; Chen HW; Liu SJ J Immunother; 2012 Apr; 35(3):235-44. PubMed ID: 22421941 [TBL] [Abstract][Full Text] [Related]
15. High frequency of prostate antigen-directed T cells in cancer patients compared to healthy age-matched individuals. Forsberg O; Carlsson B; Malmström PU; Ullenhag G; Tötterman TH; Essand M Prostate; 2009 Jan; 69(1):70-81. PubMed ID: 18814178 [TBL] [Abstract][Full Text] [Related]
16. Identification of a novel HLA-A*0201-restricted, cytotoxic T lymphocyte epitope in a human glioma-associated antigen, interleukin 13 receptor alpha2 chain. Okano F; Storkus WJ; Chambers WH; Pollack IF; Okada H Clin Cancer Res; 2002 Sep; 8(9):2851-5. PubMed ID: 12231526 [TBL] [Abstract][Full Text] [Related]
17. Therapy of established tumors in a novel murine model transgenic for human carcinoembryonic antigen and HLA-A2 with a combination of anti-idiotype vaccine and CTL peptides of carcinoembryonic antigen. Saha A; Chatterjee SK; Foon KA; Celis E; Bhattacharya-Chatterjee M Cancer Res; 2007 Mar; 67(6):2881-92. PubMed ID: 17363612 [TBL] [Abstract][Full Text] [Related]
18. Identification of HLA-A*0201-restricted CTL Epitopes for MLAA-34-specific Immunotherapy for Acute Monocytic Leukemia. Bai J; Wang J; Yang Y; Wang F; He A; Zhang W J Immunother; 2021 May; 44(4):141-150. PubMed ID: 33596023 [TBL] [Abstract][Full Text] [Related]
19. Her-2/neu-derived peptides are tumor-associated antigens expressed by human renal cell and colon carcinoma lines and are recognized by in vitro induced specific cytotoxic T lymphocytes. Brossart P; Stuhler G; Flad T; Stevanovic S; Rammensee HG; Kanz L; Brugger W Cancer Res; 1998 Feb; 58(4):732-6. PubMed ID: 9485028 [TBL] [Abstract][Full Text] [Related]
20. [In vitro induction of immune response by dendritic cells pulsed with TRAG-3-derived cytotoxic T lymphocyte epitope]. Zhu B; Chen ZT; Cheng XM; Wu YZ Zhonghua Zhong Liu Za Zhi; 2004 Dec; 26(12):709-12. PubMed ID: 15733385 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]